DRG Scientific are pioneers in crop innovation, plant science and breeding, specialising in consultancy, phenotyping and research (R&D) services. Our mission is to optimise the crop through scientific expertise and a deep commitment to the understanding of plant science, genetics and the environment.Services:1. Consultancy in Cultivation: Track recording of increasing sellable product, improving quality and offering a solutions based approach.2. Research and Development (R&D): Writing and executing comprehensive projects in advancing plant breeding techniques, enhancing Cannabis's therapeutic attributes, as well as R&D plans for license applications.3. Strategic Phenotyping: Wide network and collaborations with industry leaders and research institutions as well as legacy growers and breeders has forged a comprehensive and industry leading plant optimisation system.4. Scientific Writing and Communication: Award winning science communication credentials and skilled at writing at various levels. Articles, website copy and more, including SEO and key word optimised services.Expertise: Dr. Gary Yates, PhD, is a distinguished and versatile professional renowned for his exceptional academic achievements, dynamic research contributions, and leadership roles within the scientific community. His expertise lies at the intersection of plant science, molecular biology, and advanced cannabis cultivation, showcasing a unique skill set that encompasses problem-solving, abstract thinking, and a strong work ethic. Innovative Solutions: Stay ahead with innovative approaches to crop science. Utilise the latest technology and scientific understanding. Passionate for patient Advocacy: We advocate for the therapeutic benefits of Cannabis, reshaping perceptions positively, and increasing access to those who need it.At DGR Scientific, each project is an opportunity to make a lasting impact on the future of the industry.

PharmaSeeds is a specialist supplier of propagation materials and expertise to the growing global medical cannabis industry. Our shared ethos of achieving the highest standards of excellence in genetics, research, plant health and regulatory compliance will drive an unprecedented, positive impact on the medical cannabis industry. I lead PharmaSeeds’ product development, working with suppliers and customers to develop a ‘best in class’ catalogue of varieties and cultivars that meet and anticipate the growing demand for quality and compliant seeds. I focus on innovative and cutting-edge developments in crop science and plant breeding, encompassing for example, specific chemical profile targeting for therapeutic indications or adapting varieties to the agronomic and climatic conditions in supportive jurisdictions.